This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    27/02/18

    REVA Medical, Inc.has announced CE Mark of the 2.5 millimeter diameter size and the first implant of the Fantom Encore bioresorbable scaffold.

    REVA Medical, Inc. a leader in bioresorbable polymer technologies for vascular applications, announced CE Mark of the 2.5 millimeter diameter...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    25/02/18

    Wave Life Sciences and Takeda collaborate on nucleic acid therapies for CNS disorders including WVE 120102 for Huntington disease.

    Wave Life Sciences Ltd. , a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, announced...

    Journals
    Journal
    01/03/18

    Review of oritavancin for the treatment of acute bacterial skin and skin structure infections

    Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.

    • Source: Farmacia Hospitalaria
    A close up image of a microscope
    Clinical trial
    01/03/22

    Macular Pigment and Visual Performance in Glaucoma Patients

    The purpose of this study is to determine cross-sectional relationships between macular pigment optical density (MPOD) and visual performance in glaucoma

    • Source: ClinicalTrials.gov
    Journals
    Journal
    31/03/19

    Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.

    Aggregation of alpha-synuclein (alpha-syn) is neuropathologically and genetically linked to Parkinson's disease (PD). Since stereotypic cell-to-cell spreading of alpha-syn pathology is believed to contribute to disease progression...

    • Source: Neurobiology of Disease
    Journals
    Journal
    01/03/22

    Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning

    Background: Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. Although there is an increased understanding of AA pathogenesis and progress in its treatments, the outcome of AA patients remains unfavorable, especially when they are progressing to the subtypes of alopecia totalis (AT) or alopecia universalis (AU).

    • Source: Dermatology
    Journals
    Journal
    31/08/17

    Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa

    Introduction: Hidradenitis suppurativa (HS) is a serious, debilitating, chronic inflammatory skin disease. Adalimumab is a fully human, immunoglobulin G1 monoclonal antibody specific for tumor necrosis factor-alpha...

    • Source: Clinical Pharmacokinetics
    Journals
    Journal
    01/03/19

    Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Risk for late-onset Alzheimer's disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-analysis of clinically diagnosed LOAD (94,437 individuals).

    • Source: Nature Genetics
    Journals
    Journal
    07/02/17

    Analysis of the association of chronic spontaneous urticaria with interlekin-4, -10, transforming growth factor-β1, interferon-γ, interleukin-17A and -23 by autologous serum skin test

    To contribute to the understanding of the pathogenesis of chronic spontaneous urticaria (CSU) by identifying its relationship with autoimmunity and cytokines using the autologous serum skin test (ASST)...

    • Source: Advances in Dermatology and Allergology
    Latest industry news
    Industry news
    17/05/24

    First Wave BioPharma changes its name to Entero Therapeutics

    Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, unveiled its new corporate name and website.

    See more